Lessened splenomegaly; reduced kidney inflammation; decreased anti-histone and anti-nuclear antibodies; transient decline of hypergammaglobulinemia and anti-histone, anti-La, anti-dsRNA, and anti-RNP antibodies. This evidence concerns the gene RNPC3 and Splenomegaly.